Literature DB >> 14760137

Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.

B Arora, L Kumar, A Sharma, J Wadhwa, V Kochupillai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760137     DOI: 10.1093/annonc/mdh068

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  14 in total

1.  Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib.

Authors:  Karim Boudadi; Rashmi Chugh
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Mucosal pigmentation caused by imatinib: report of three cases.

Authors:  Chia-Cheng Li; Salman M Malik; Bart F Blaeser; Walid J Dehni; Sadru P Kabani; Niamh Boyle; Mary Toner; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-12-31

Review 3.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

4.  Mucosal pigmentation of the hard palate in a patient taking imatinib.

Authors:  Alexandra Lyne; Alex Creedon; Basil Malcolm West Bailey
Journal:  BMJ Case Rep       Date:  2015-04-16

Review 5.  Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review.

Authors:  Veerandra Kumar; Priyanka Singh; Sonu Kumar Gupta; Villayat Ali; Malkhey Verma
Journal:  Mol Cell Biochem       Date:  2022-02-07       Impact factor: 3.396

6.  Treatment of chronic phase chronic myeloid leukemia with imatinib.

Authors:  Prasanth Ganesan; Rejiv Rajendranath; Vignesh Kandakumar; Tenali Gnana Sagar
Journal:  Indian J Pediatr       Date:  2014-05-30       Impact factor: 1.967

7.  Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Authors:  Tariq I Mughal; Andrew Schrieber
Journal:  Biologics       Date:  2010-12-02

Review 8.  Cutaneous complications of molecular targeted therapy used in oncology.

Authors:  I Lupu; N Voiculescu; N Bacalbasa; I Cojocaru; V Vrancian; C Giurcaneanu
Journal:  J Med Life       Date:  2016 Jan-Mar

9.  Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib.

Authors:  Gian Paolo Bombeccari; Umberto Garagiola; Francesco Pallotti; Margherita Rossi; Massimo Porrini; Aldo Bruno Giannì; Francesco Spadari
Journal:  Maxillofac Plast Reconstr Surg       Date:  2017-12-05

10.  Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules.

Authors:  Ju Wang Jang; Chang Hwa Song; You Jin Jung; Dong Uk Cheon; Won Seon Koh; Young Suck Ro; Joo Yeon Ko
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.